{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35028002", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "04"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "01", "Day": "04"}], "Language": ["eng"], "ELocationID": ["1458143", "10.1155/2022/1458143"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2022", "PubDate": {"Year": "2022"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer.", "Pagination": {"StartPage": "1458143", "MedlinePgn": "1458143"}, "Abstract": {"AbstractText": ["Artemisinin (ART) is a bioactive molecule derived from the Chinese medicinal plant Artemisia annua (Asteraceae). ART and artemisinin derivatives (ARTs) have been effectively used for antimalaria treatment. The structure of ART is composed of a sesquiterpene lactone, including a peroxide internal bridge that is essential for its activity. In addition to their well-known antimalarial effects, ARTs have been shown recently to resist a wide range of tumors. The antineoplastic mechanisms of ART mainly include cell cycle inhibition, inhibition of tumor angiogenesis, DNA damage, and ferroptosis. In particular, ferroptosis is a novel nonapoptotic type of programmed cell death. However, the antitumor mechanisms of ARTs by regulating ferroptosis remain unclear. Through this review, we focus on the potential antitumor function of ARTs by acting on ferroptosis, including the regulation of iron metabolism, generation of reactive oxygen species (ROS), and activation of endoplasmic reticulum stress (ERS). This article systematically reviews the recent progress in ferroptosis research and provides a basis for ARTs as an anticancer drug in clinical practice."], "CopyrightInformation": "Copyright \u00a9 2022 Yingying Hu et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southwest Medical University, Luzhou, China 6460."}], "LastName": "Hu", "ForeName": "Yingying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southwest Medical University, Luzhou, China 6460."}], "LastName": "Guo", "ForeName": "Nan", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southwest Medical University, Luzhou, China 6460."}], "LastName": "Yang", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southwest Medical University, Luzhou, China 6460."}], "LastName": "Yan", "ForeName": "Jianghong", "Initials": "J"}, {"Identifier": ["0000-0002-1102-3932"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute for Cancer Medicine and School of Basic Medical Sciences, Southwest Medical University, Luzhou, China 646000."}], "LastName": "Wang", "ForeName": "Wenjun", "Initials": "W"}, {"Identifier": ["0000-0002-0535-3759"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southwest Medical University, Luzhou, China 6460."}], "LastName": "Li", "ForeName": "Xiang", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "9RMU91N5K2", "NameOfSubstance": "artemisinin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Artemisinins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Ferroptosis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants"}], "CoiStatement": "The authors declare no competing financial interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Klayman D. Qinghaosu (artemisinin): an antimalarial drug from China. Science (New York, N.Y.) . 1985;228(4703):1049\u20131055. doi: 10.1126/science.3887571.", "ArticleIdList": ["10.1126/science.3887571", "3887571"]}, {"Citation": "Hien T. T., White N. J. Qinghaosu. Lancet . 1993;341(8845):603\u2013608. doi: 10.1016/0140-6736(93)90362-K.", "ArticleIdList": ["10.1016/0140-6736(93)90362-K", "8094838"]}, {"Citation": "Kannan R., Kumar K., Sahal D., Kukreti S., Chauhan V. S. Reaction of artemisinin with haemoglobin: implications for antimalarial activity. Biochemical Journal . 2005;385(2):409\u2013418. doi: 10.1042/BJ20041170.", "ArticleIdList": ["10.1042/BJ20041170", "PMC1134711", "15361062"]}, {"Citation": "Wang J., Tang W., Zhou R., et al. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses. British Journal of Pharmacology . 2008;153(6):1303\u20131310. doi: 10.1038/bjp.2008.11.", "ArticleIdList": ["10.1038/bjp.2008.11", "PMC2275452", "18264129"]}, {"Citation": "Li J., Casteels T., Frogne T., et al. Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity. Cell . 2017;168(1-2):86\u2013100.e15. doi: 10.1016/j.cell.2016.11.010.", "ArticleIdList": ["10.1016/j.cell.2016.11.010", "PMC5236063", "27916275"]}, {"Citation": "Li W. D., Dong Y. J., Tu Y. Y., Lin Z. B. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. International Immunopharmacology . 2006;6(8):1243\u20131250. doi: 10.1016/j.intimp.2006.03.004.", "ArticleIdList": ["10.1016/j.intimp.2006.03.004", "16782536"]}, {"Citation": "Du J. H., Zhang H. D., Ma Z. J., Ji K. M. Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemotherapy and Pharmacology . 2010;65(5):895\u2013902. doi: 10.1007/s00280-009-1095-5.", "ArticleIdList": ["10.1007/s00280-009-1095-5", "PMC2824122", "19690861"]}, {"Citation": "Zhou C., Pan W., Xiao P. W., Tong S. C. Artesunate induces apoptosis via a Bak-mediated caspase-independent intrinsic pathway in human lung adenocarcinoma cells. Journal of Cellular Physiology . 2012;227(12):3778\u20133786. doi: 10.1002/jcp.24086.", "ArticleIdList": ["10.1002/jcp.24086", "22378505"]}, {"Citation": "Zhao Y., Jiang W., Li B., et al. Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase. International Immunopharmacology . 2011;11(12):2039\u20132046. doi: 10.1016/j.intimp.2011.08.017.", "ArticleIdList": ["10.1016/j.intimp.2011.08.017", "21907831"]}, {"Citation": "Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochemical Pharmacology . 2004;68(12):2359\u20132366. doi: 10.1016/j.bcp.2004.08.021.", "ArticleIdList": ["10.1016/j.bcp.2004.08.021", "15548382"]}, {"Citation": "Rasheed S. A. K., Efferth T., Asangani I. A., Allgayer H. First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. International Journal of Cancer Journal International Du Cancer . 2010;127(6):1475\u20131485. doi: 10.1002/ijc.25315.", "ArticleIdList": ["10.1002/ijc.25315", "20232396"]}, {"Citation": "Berdelle N., Nikolova T., Quiros S., Efferth T., Kaina B. Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Molecular Cancer Therapeutics . 2011;10(12):2224\u20132233. doi: 10.1158/1535-7163.MCT-11-0534.", "ArticleIdList": ["10.1158/1535-7163.MCT-11-0534", "21998290"]}, {"Citation": "Li P., Lam E., Roos W., Zdzienicka M., Kaina B., Efferth T. Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Research . 2008;68(11):4347\u20134351. doi: 10.1158/0008-5472.CAN-07-2970.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2970", "18519695"]}, {"Citation": "Wang B., Hou D., Liu Q., et al. Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51. Cancer Biology & Therapy . 2015;16(10):1548\u20131556. doi: 10.1080/15384047.2015.1071738.", "ArticleIdList": ["10.1080/15384047.2015.1071738", "PMC5391513", "26176175"]}, {"Citation": "Lam N., Long X., Wong J., Griffin R., Doery J. Artemisinin and its derivatives: a potential treatment for leukemia. Anti-Cancer Drugs . 2019;30(1):1\u201318. doi: 10.1097/CAD.0000000000000697.", "ArticleIdList": ["10.1097/CAD.0000000000000697", "30540593"]}, {"Citation": "Efferth T. Cancer combination therapies with artemisinin-type drugs. Biochemical Pharmacology . 2017;139:56\u201370. doi: 10.1016/j.bcp.2017.03.019.", "ArticleIdList": ["10.1016/j.bcp.2017.03.019", "28366726"]}, {"Citation": "Kumar M., Yadav T., Khair R., Peters G., Yergeri M. Combination therapies of artemisinin and its derivatives as a viable approach for future cancer treatment. Current Pharmaceutical Design . 2019;25(31):3323\u20133338. doi: 10.2174/1381612825666190902155957.", "ArticleIdList": ["10.2174/1381612825666190902155957", "31475891"]}, {"Citation": "Dixon S. J., Lemberg K. M., Lamprecht M. R., et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell . 2012;149(5):1060\u20131072. doi: 10.1016/j.cell.2012.03.042.", "ArticleIdList": ["10.1016/j.cell.2012.03.042", "PMC3367386", "22632970"]}, {"Citation": "Wan S. Y., Stockwell B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chemistry & Biology . 2008;15(3):234\u2013245. doi: 10.1016/j.chembiol.2008.02.010.", "ArticleIdList": ["10.1016/j.chembiol.2008.02.010", "PMC2683762", "18355723"]}, {"Citation": "Dolma S., Lessnick S. L., Hahn W. C., Stockwell B. R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell . 2003;3(3):285\u2013296. doi: 10.1016/S1535-6108(03)00050-3.", "ArticleIdList": ["10.1016/S1535-6108(03)00050-3", "12676586"]}, {"Citation": "Dixon S. J., Stockwell B. R. The role of iron and reactive oxygen species in cell death. Nature Chemical Biology . 2014;10(1):9\u201317. doi: 10.1038/nchembio.1416.", "ArticleIdList": ["10.1038/nchembio.1416", "24346035"]}, {"Citation": "Yang W. S., Sriramaratnam R., Welsch M. E., et al. Regulation of ferroptotic cancer cell death by GPX4. Cell . 156(1-2):317\u2013331. doi: 10.1016/j.cell.2013.12.010.", "ArticleIdList": ["10.1016/j.cell.2013.12.010", "PMC4076414", "24439385"]}, {"Citation": "Ursini F., Maiorino M., Valente M., Ferri L., Gregolin C. Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides. Biochimica et Biophysica Acta . 1982;710(2):197\u2013211. doi: 10.1016/0005-2760(82)90150-3.", "ArticleIdList": ["10.1016/0005-2760(82)90150-3", "7066358"]}, {"Citation": "Thomas J. P., Geiger P. G., Maiorino M., Ursini F., Girotti A. W. Enzymatic reduction of phospholipid and cholesterol hydroperoxides in artificial bilayers and lipoproteins. Biochimica et Biophysica Acta . 1990;1045(3):252\u2013260. doi: 10.1016/0005-2760(90)90128-K.", "ArticleIdList": ["10.1016/0005-2760(90)90128-K", "2386798"]}, {"Citation": "Parillo F., Sylla L., Palombi C., Monaci M., Stradaioli G. Immunocytochemical localisation of phospholipid hydroperoxide glutathione peroxidase in bull\u2019s spermatogenic cells. Italian Journal of Animal Science . 2014;13(3) doi: 10.4081/ijas.2014.3483.", "ArticleIdList": ["10.4081/ijas.2014.3483"]}, {"Citation": "Friedmann Angeli J. P., Schneider M., Proneth B., et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Free Radical Biology & Medicine . 2014;16(12):1180\u20131191. doi: 10.1038/ncb3064.", "ArticleIdList": ["10.1038/ncb3064", "PMC4894846", "25402683"]}, {"Citation": "Chen L., Hambright W. S., Na R., Ran Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. Journal of Biological Chemistry . 2015;290(47):28097\u201328106. doi: 10.1074/jbc.M115.680090.", "ArticleIdList": ["10.1074/jbc.M115.680090", "PMC4653669", "26400084"]}, {"Citation": "Sato H., Tamba M., Ishii T., Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins\u2217. The Journal of Biological Chemistry . 1999;274(17):11455\u201311458. doi: 10.1074/jbc.274.17.11455.", "ArticleIdList": ["10.1074/jbc.274.17.11455", "10206947"]}, {"Citation": "Bridges R. J., Natale N. R., Patel S. A. System xc\u2212 cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. British Journal of Pharmacology . 2012;165(1):20\u201334. doi: 10.1111/j.1476-5381.2011.01480.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01480.x", "PMC3252963", "21564084"]}, {"Citation": "Feng H., Stockwell B. R. Unsolved mysteries: how does lipid peroxidation cause ferroptosis? PLoS Biology . 2018;16(5, article e2006203) doi: 10.1371/journal.pbio.2006203.", "ArticleIdList": ["10.1371/journal.pbio.2006203", "PMC5991413", "29795546"]}, {"Citation": "Dixon S. J., Patel D. N., Matthew W., et al. Pharmacological inhibition of cystine\u2013glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife . 2014;3:p. e02523. doi: 10.7554/eLife.02523.", "ArticleIdList": ["10.7554/eLife.02523", "PMC4054777", "24844246"]}, {"Citation": "Yu H., Yang C., Jian L., et al. Sulfasalazine-induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncology Reports . 2019;42(2):826\u2013838. doi: 10.3892/or.2019.7189.", "ArticleIdList": ["10.3892/or.2019.7189", "31173262"]}, {"Citation": "Louandre C., Marcq I., Bouhlal H., et al. The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells. Cancer Letters . 2015;356(2):971\u2013977. doi: 10.1016/j.canlet.2014.11.014.", "ArticleIdList": ["10.1016/j.canlet.2014.11.014", "25444922"]}, {"Citation": "Graham B. H., Craigen W. J. Genetic approaches to analyzing mitochondrial outer membrane permeability. Current Topics in Developmental Biology . 2004;59:87\u2013118. doi: 10.1016/S0070-2153(04)59004-X.", "ArticleIdList": ["10.1016/S0070-2153(04)59004-X", "14975248"]}, {"Citation": "Yagoda N., Von Rechenberg M., Zaganjor E., et al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature . 447(7146):865\u2013869. doi: 10.1038/nature05859.", "ArticleIdList": ["10.1038/nature05859", "PMC3047570", "17568748"]}, {"Citation": "Maldonado E. N., Sheldon K. L., DeHart D. N., et al. Voltage-dependent anion channels modulate mitochondrial metabolism in cancer cells. The Journal of Biological Chemistry . 2013;288(17):11920\u201311929. doi: 10.1074/jbc.M112.433847.", "ArticleIdList": ["10.1074/jbc.M112.433847", "PMC3636879", "23471966"]}, {"Citation": "Eling N., Reuter L., Hazin J., Hamacher-Brady A., Brady N. R. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience . 2015;2(5):517\u2013532. doi: 10.18632/oncoscience.160.", "ArticleIdList": ["10.18632/oncoscience.160", "PMC4468338", "26097885"]}, {"Citation": "Yu Y., Xie Y., Cao L., et al. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Molecular & Cellular Oncology . 2015;2(4, article e1054549) doi: 10.1080/23723556.2015.1054549.", "ArticleIdList": ["10.1080/23723556.2015.1054549", "PMC4905356", "27308510"]}, {"Citation": "Feng H., Schorpp K., Jin J., et al. Transferrin receptor is a specific ferroptosis marker. Cell Reports . 2020;30(10):3411\u20133423.e7. doi: 10.1016/j.celrep.2020.02.049.", "ArticleIdList": ["10.1016/j.celrep.2020.02.049", "PMC7172030", "32160546"]}, {"Citation": "Gao M., Monian P., Quadri N., Ramasamy R., Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Molecular Cell . 2015;59(2):298\u2013308. doi: 10.1016/j.molcel.2015.06.011.", "ArticleIdList": ["10.1016/j.molcel.2015.06.011", "PMC4506736", "26166707"]}, {"Citation": "Lv H., Shang P. The significance, trafficking and determination of labile iron in cytosol, mitochondria and lysosomes. Metallomics . 2018;10(7):899\u2013916. doi: 10.1039/C8MT00048D.", "ArticleIdList": ["10.1039/C8MT00048D", "29923582"]}, {"Citation": "Jiang L., Hickman J. H., Wang S. J., Gu W. Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses. Cell Cycle . 2015;14(18):2881\u20132885. doi: 10.1080/15384101.2015.1068479.", "ArticleIdList": ["10.1080/15384101.2015.1068479", "PMC4825584", "26218928"]}, {"Citation": "Jiang L., Kon N., Li T., et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature . 2015;520(7545):57\u201362. doi: 10.1038/nature14344.", "ArticleIdList": ["10.1038/nature14344", "PMC4455927", "25799988"]}, {"Citation": "Sun X., Ou Z., Xie M., et al. HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene . 2015;34(45):5617\u20135625. doi: 10.1038/onc.2015.32.", "ArticleIdList": ["10.1038/onc.2015.32", "PMC4640181", "25728673"]}, {"Citation": "Sun X., Ou Z., Chen R., et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology . 2016;63(1):173\u2013184. doi: 10.1002/hep.28251.", "ArticleIdList": ["10.1002/hep.28251", "PMC4688087", "26403645"]}, {"Citation": "Roh J. L., Kim E. H., Jang H., Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biology . 2017;11:254\u2013262. doi: 10.1016/j.redox.2016.12.010.", "ArticleIdList": ["10.1016/j.redox.2016.12.010", "PMC5198738", "28012440"]}, {"Citation": "Very low intensity ultrasounds as a new strategy to improve selective delivery of nanoparticles-complexes in cancer cells. Journal of Experimental & Clinical Cancer Research . 2019;38(1):1\u201316. doi: 10.1186/s13046-018-1018-6.", "ArticleIdList": ["10.1186/s13046-018-1018-6", "PMC6318873", "30606223"]}, {"Citation": "Zhao F., Vakhrusheva O., Markowitsch S., et al. Artesunate impairs growth in cisplatin-resistant bladder cancer cells by cell cycle arrest, apoptosis and autophagy induction. Cell . 2020;9(12):p. 2643. doi: 10.3390/cells9122643.", "ArticleIdList": ["10.3390/cells9122643", "PMC7763932", "33316936"]}, {"Citation": "Ooko E., Saeed M. E., Kadioglu O., et al. Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells. Phytomedicine . 2015;22(11):1045\u20131054. doi: 10.1016/j.phymed.2015.08.002.", "ArticleIdList": ["10.1016/j.phymed.2015.08.002", "26407947"]}, {"Citation": "Aulbert E., Disselhoff W., S\u00f6rje H., Schulz E., Gericke D. Lysosomal accumulation of 67Ga-transferrin in malignant tumors in relation to their growth rate. European Journal of Cancer . 1980;16(9):1217\u20131232. doi: 10.1016/0014-2964(80)90181-4.", "ArticleIdList": ["10.1016/0014-2964(80)90181-4", "6262089"]}, {"Citation": "Gatter K., Brown G., Trowbridge I., Woolston R., Mason D. Transferrin receptors in human tissues: their distribution and possible clinical relevance. Journal of Clinical Pathology . 1983;36(5):539\u2013545. doi: 10.1136/jcp.36.5.539.", "ArticleIdList": ["10.1136/jcp.36.5.539", "PMC498283", "6302135"]}, {"Citation": "Shterman N., Kupfer B., Moroz C. Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines. Pathobiology : journal of immunopathology, molecular and cellular biology . 1991;59(1):19\u201325. doi: 10.1159/000163611.", "ArticleIdList": ["10.1159/000163611", "2043266"]}, {"Citation": "Judd W., Poodry C., Strominger J. Novel surface antigen expressed on dividing cells but absent from nondividing cells. The Journal of Experimental Medicine . 1980;152:1430\u20131435. doi: 10.1084/jem.152.5.1430.", "ArticleIdList": ["10.1084/jem.152.5.1430", "PMC2186001", "6968814"]}, {"Citation": "Sutherland R., Delia D., Schneider C., Newman R., Kemshead J., Greaves M. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proceedings of the National Academy of Sciences of the United States of America . 1981;78(7):4515\u20134519. doi: 10.1073/pnas.78.7.4515.", "ArticleIdList": ["10.1073/pnas.78.7.4515", "PMC319822", "6270680"]}, {"Citation": "Ba Q., Zhou N., Duan J., et al. Dihydroartemisinin exerts its anticancer activity through depleting cellular iron via transferrin receptor-1. PLoS One . 2012;7(8, article e42703) doi: 10.1371/journal.pone.0042703.", "ArticleIdList": ["10.1371/journal.pone.0042703", "PMC3416848", "22900042"]}, {"Citation": "Cao J. Y., Dixon S. J. Mechanisms of ferroptosis. Cellular and Molecular Life Sciences . 2016;73(11-12):2195\u20132209. doi: 10.1007/s00018-016-2194-1.", "ArticleIdList": ["10.1007/s00018-016-2194-1", "PMC4887533", "27048822"]}, {"Citation": "Lin R., Zhang Z., Chen L., et al. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Letters . 2016;381(1):165\u2013175. doi: 10.1016/j.canlet.2016.07.033.", "ArticleIdList": ["10.1016/j.canlet.2016.07.033", "27477901"]}, {"Citation": "Greenshields A. L., Shepherd T. G., Hoskin D. W. Contribution of reactive oxygen species to ovarian cancer cell growth arrest and killing by the anti-malarial drug artesunate. Molecular Carcinogenesis . 2017;56(1):75\u201393. doi: 10.1002/mc.22474.", "ArticleIdList": ["10.1002/mc.22474", "26878598"]}, {"Citation": "Louandre C., Ezzoukhry Z., Godin C., et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. International Journal of Cancer . 2013;133(7):1732\u20131742. doi: 10.1002/ijc.28159.", "ArticleIdList": ["10.1002/ijc.28159", "23505071"]}, {"Citation": "Skouta R., Dixon S. J., Wang J., et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. Journal of the American Chemical Society . 2014;136(12):4551\u20134556. doi: 10.1021/ja411006a.", "ArticleIdList": ["10.1021/ja411006a", "PMC3985476", "24592866"]}, {"Citation": "Torti S. V., Torti F. M. Iron and cancer: more ore to be mined. Nature Reviews Cancer . 2013;13(5):342\u2013355. doi: 10.1038/nrc3495.", "ArticleIdList": ["10.1038/nrc3495", "PMC4036554", "23594855"]}, {"Citation": "Dowdle W. E., Nyfeler B., Nagel J., et al. Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis _in vivo_. Nature Cell Biology . 2014;16(11):1069\u20131079. doi: 10.1038/ncb3053.", "ArticleIdList": ["10.1038/ncb3053", "25327288"]}, {"Citation": "Chen G. Q., Benthani F. A., Wu J., Liang D., Bian Z. X., Jiang X. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death and Differentiation . 2020;27(1):242\u2013254. doi: 10.1038/s41418-019-0352-3.", "ArticleIdList": ["10.1038/s41418-019-0352-3", "PMC7205875", "31114026"]}, {"Citation": "Yang N. D., Tan S. H., Ng S., et al. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin\u2217. Journal of Biological Chemistry . 2014;289(48):33425\u201333441. doi: 10.1074/jbc.M114.564567.", "ArticleIdList": ["10.1074/jbc.M114.564567", "PMC4246098", "25305013"]}, {"Citation": "Hou W., Xie Y., Song X., et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy . 2016;12:1425\u20131428. doi: 10.1080/15548627.2016.1187366.", "ArticleIdList": ["10.1080/15548627.2016.1187366", "PMC4968231", "27245739"]}, {"Citation": "Mancias J. D., Wang X., Gygi S. P., Harper J. W., Kimmelman A. C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature . 2014;509(7498):105\u2013109. doi: 10.1038/nature13148.", "ArticleIdList": ["10.1038/nature13148", "PMC4180099", "24695223"]}, {"Citation": "Du J., Wang T., Li Y., et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radical Biology & Medicine . 2019;131:356\u2013369. doi: 10.1016/j.freeradbiomed.2018.12.011.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.12.011", "30557609"]}, {"Citation": "Ozben T. Oxidative stress and apoptosis: impact on cancer therapy. Journal of Pharmaceutical Ences . 2010;96(9):2181\u20132196.", "ArticleIdList": ["17593552"]}, {"Citation": "Pandey A., Tekwani B., Singh R., Chauhan V. Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. The Journal of Biological Chemistry . 1999;274(27):19383\u201319388. doi: 10.1074/jbc.274.27.19383.", "ArticleIdList": ["10.1074/jbc.274.27.19383", "10383451"]}, {"Citation": "O\u2019neill P. M., Barton V. E., Ward S. A. The molecular mechanism of action of artemisinin-the debate continues. Molecules . 2010;15(3):1705\u20131721. doi: 10.3390/molecules15031705.", "ArticleIdList": ["10.3390/molecules15031705", "PMC6257357", "20336009"]}, {"Citation": "Efferth T. Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside. Planta Medica . 2007;73(4):299\u2013309. doi: 10.1055/s-2007-967138.", "ArticleIdList": ["10.1055/s-2007-967138", "17354163"]}, {"Citation": "Gautam A., Ahmed T., Batra V., Paliwal J. Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials. Current Drug Metabolism . 2009;10(3):289\u2013306. doi: 10.2174/138920009787846323.", "ArticleIdList": ["10.2174/138920009787846323", "19442090"]}, {"Citation": "Mercer A., Maggs J., Sun X., et al. Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. The Journal of Biological Chemistry . 2007;282(13):9372\u20139382. doi: 10.1074/jbc.M610375200.", "ArticleIdList": ["10.1074/jbc.M610375200", "17227762"]}, {"Citation": "Mercer A., Copple I., Maggs J., O'Neill P., Park B. The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials. The Journal of Biological Chemistry . 2011;286(2):987\u2013996. doi: 10.1074/jbc.M110.144188.", "ArticleIdList": ["10.1074/jbc.M110.144188", "PMC3020783", "21059641"]}, {"Citation": "Efferth T., Briehl M. M., Tome M. E. Role of antioxidant genes for the activity of artesunate against tumor cells. International Journal of Oncology . 2003;23(4):1231\u20131235. doi: 10.3892/ijo.23.4.1231.", "ArticleIdList": ["10.3892/ijo.23.4.1231", "12964009"]}, {"Citation": "Hamacher-Brady A., Stein H. A., Turschner S., et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. Journal of Biological Chemistry . 2011;286(8):6587\u20136601. doi: 10.1074/jbc.M110.210047.", "ArticleIdList": ["10.1074/jbc.M110.210047", "PMC3057810", "21149439"]}, {"Citation": "Efferth T., Oesch F. Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. Biochemical Pharmacology . 2004;68(1):3\u201310. doi: 10.1016/j.bcp.2004.03.003.", "ArticleIdList": ["10.1016/j.bcp.2004.03.003", "15183112"]}, {"Citation": "Horwedel C., Tsogoeva S. B., Wei S., Efferth T. Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells. Journal of Medicinal Chemistry . 2010;53(13):4842\u20134848. doi: 10.1021/jm100404t.", "ArticleIdList": ["10.1021/jm100404t", "20527917"]}, {"Citation": "Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions . 2006;160(1):1\u201340. doi: 10.1016/j.cbi.2005.12.009.", "ArticleIdList": ["10.1016/j.cbi.2005.12.009", "16430879"]}, {"Citation": "Shintoku R., Takigawa Y., Yamada K., Kubota C., Torii S. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3. Cancer Science . 2017;108(11):2187\u20132194. doi: 10.1111/cas.13380.", "ArticleIdList": ["10.1111/cas.13380", "PMC5666033", "28837253"]}, {"Citation": "Efferth T., Olbrich A., Bauer R. mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochemical Pharmacology . 2002;64(4):617\u2013623. doi: 10.1016/S0006-2952(02)01221-2.", "ArticleIdList": ["10.1016/S0006-2952(02)01221-2", "12167480"]}, {"Citation": "Efferth T., Sauerbrey A., Olbrich A., et al. Molecular modes of action of artesunate in tumor cell lines. Molecular Pharmacology . 2003;64(2):382\u2013394. doi: 10.1124/mol.64.2.382.", "ArticleIdList": ["10.1124/mol.64.2.382", "12869643"]}, {"Citation": "Toth K., Spencer J., Tollefson A., et al. Cotton rat tumor model for the evaluation of oncolytic adenoviruses. Human Gene Therapy . 2005;16(1):139\u2013146. doi: 10.1089/hum.2005.16.139.", "ArticleIdList": ["10.1089/hum.2005.16.139", "15703497"]}, {"Citation": "Wang Z., Hu W., Zhang J., Wu X., Zhou H. Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity. FEBS Open Bio . 2012;2(1):103\u2013112. doi: 10.1016/j.fob.2012.05.002.", "ArticleIdList": ["10.1016/j.fob.2012.05.002", "PMC3642128", "23650588"]}, {"Citation": "Zhu H., Liao S., Shi J., et al. DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal. Free Radical Biology & Medicine . 2014;71:121\u2013132. doi: 10.1016/j.freeradbiomed.2014.03.026.", "ArticleIdList": ["10.1016/j.freeradbiomed.2014.03.026", "24681255"]}, {"Citation": "Jia J., Qin Y., Zhang L., et al. Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis. Molecular Medicine Reports . 2016;13(5):4461\u20134468. doi: 10.3892/mmr.2016.5073.", "ArticleIdList": ["10.3892/mmr.2016.5073", "27035431"]}, {"Citation": "Lemke D., Pledl H., Zorn M., et al. Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapy. Induction of oxidative stress in murine glioblastoma therapy, Oncotarget . 2016;7(35):56713\u201356725. doi: 10.18632/oncotarget.10723.", "ArticleIdList": ["10.18632/oncotarget.10723", "PMC5302947", "27447560"]}, {"Citation": "Zhu S., Yu Q., Huo C., et al. Ferroptosis: a novel mechanism of artemisinin and its derivatives in cancer therapy. Current Medicinal Chemistry . 2020;28(2):329\u2013345. doi: 10.2174/0929867327666200121124404.", "ArticleIdList": ["10.2174/0929867327666200121124404", "31965935"]}, {"Citation": "Yi R., Wang H., Deng C., et al. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition. Bioscience Reports . 2020;40(6) doi: 10.1042/BSR20193314.", "ArticleIdList": ["10.1042/BSR20193314", "PMC7313443", "32452511"]}, {"Citation": "Ishikawa C., Senba M., Mori N. Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma. European Journal of Pharmacology . 2020;872, article 172953 doi: 10.1016/j.ejphar.2020.172953.", "ArticleIdList": ["10.1016/j.ejphar.2020.172953", "31996318"]}, {"Citation": "Sporn M., Liby K. NRF2 and cancer: the good, the bad and the importance of context. Nature Reviews. Cancer . 2012;12(8):564\u2013571. doi: 10.1038/nrc3278.", "ArticleIdList": ["10.1038/nrc3278", "PMC3836441", "22810811"]}, {"Citation": "Gorrini C., Harris I., Mak T. Modulation of oxidative stress as an anticancer strategy. Nature Reviews. Drug Discovery . 2013;12(12):931\u2013947. doi: 10.1038/nrd4002.", "ArticleIdList": ["10.1038/nrd4002", "24287781"]}, {"Citation": "Yang W., Stockwell B. Ferroptosis: death by lipid peroxidation. Trends in Cell Biology . 2016;26(3):165\u2013176. doi: 10.1016/j.tcb.2015.10.014.", "ArticleIdList": ["10.1016/j.tcb.2015.10.014", "PMC4764384", "26653790"]}, {"Citation": "Liu S., Xu S., Wei R., Cui Z., Chen W. Keap1 cystenine 151 as a potential target for artemisitene-induced Nrf2 activation. BioMed Research International . 2019;2019:8. doi: 10.1155/2019/5198138.", "ArticleIdList": ["10.1155/2019/5198138", "PMC6815614", "31737667"]}, {"Citation": "Zhang Y., Li F., Song Y., et al. Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis. The FASEB Journal . 2016;30(10):3474\u20133488.", "ArticleIdList": ["27383182"]}, {"Citation": "Cao S. S., Kaufman R. J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. Antioxidants & Redox Signaling . 2014;21(3):396\u2013413. doi: 10.1089/ars.2014.5851.", "ArticleIdList": ["10.1089/ars.2014.5851", "PMC4076992", "24702237"]}, {"Citation": "Wang N., Zeng G. Z., Yin J. L., Bian Z. X. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's lymphoma. Biochemical and Biophysical Research Communications . 2019;519(3):533\u2013539. doi: 10.1016/j.bbrc.2019.09.023.", "ArticleIdList": ["10.1016/j.bbrc.2019.09.023", "31537387"]}, {"Citation": "Hong S. H., Dae-Hee L., Young-Sun L., et al. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget . 2017;8(70):115164\u2013115178. doi: 10.18632/oncotarget.23046.", "ArticleIdList": ["10.18632/oncotarget.23046", "PMC5777762", "29383150"]}, {"Citation": "Asano T., Komatsu M., Yamaguchi-Iwai Y., Ishikawa F., Mizushima N., Iwai K. Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Molecular and Cellular Biology . 2011;31(10):2040\u20132052. doi: 10.1128/MCB.01437-10.", "ArticleIdList": ["10.1128/MCB.01437-10", "PMC3133360", "21444722"]}, {"Citation": "Bogdan A. R., Miyazawa M., Hashimoto K., Tsuji Y. Regulators of iron homeostasis: new players in metabolism, cell death, and disease. Cell Death, and Disease, Trends Biochem Sci . 2016;41(3):274\u2013286. doi: 10.1016/j.tibs.2015.11.012.", "ArticleIdList": ["10.1016/j.tibs.2015.11.012", "PMC4783254", "26725301"]}, {"Citation": "Liu Y., Lok C. N., Ko B. C., Shum T. Y., Wong M. K., Che C. M. Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum. Organic Letters . 2010;12(7):1420\u20131423. doi: 10.1021/ol902890j.", "ArticleIdList": ["10.1021/ol902890j", "20192248"]}, {"Citation": "Wipf P., Xiao J., Jiang J., et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin\u2212TEMPO conjugates. Journal of the American Chemical Society . 2005;127(36):12460\u201312461. doi: 10.1021/ja053679l.", "ArticleIdList": ["10.1021/ja053679l", "16144372"]}, {"Citation": "Ji J., Kline A., Amoscato A., et al. Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury. Nature Neuroscience . 2012;15(10):1407\u20131413. doi: 10.1038/nn.3195.", "ArticleIdList": ["10.1038/nn.3195", "PMC3697869", "22922784"]}, {"Citation": "Papanikolaou X., Johnson S., Garg T., Tian E., Heuck C. Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget . 2014;5(12):4118\u20134128. doi: 10.18632/oncotarget.1847.", "ArticleIdList": ["10.18632/oncotarget.1847", "PMC4147310", "24948357"]}, {"Citation": "Qin G., Wu L., Liu H., et al. Artesunate induces apoptosis via a ROS-independent and Bax-mediated intrinsic pathway in HepG2 cells. Experimental Cell Research . 2015;336(2):308\u2013317. doi: 10.1016/j.yexcr.2015.07.004.", "ArticleIdList": ["10.1016/j.yexcr.2015.07.004", "26163896"]}, {"Citation": "Yuan B., Liao F., Shi Z., et al. Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/SLC7A11 axis. Oncotargets and Therapy . 2020;13:10829\u201310840. doi: 10.2147/OTT.S248492.", "ArticleIdList": ["10.2147/OTT.S248492", "PMC7602909", "33149601"]}, {"Citation": "Wang L., Zhang Z., Li M., et al. P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation. IUBMB Life . 2019;71(1):45\u201356. doi: 10.1002/iub.1895.", "ArticleIdList": ["10.1002/iub.1895", "30321484"]}, {"Citation": "Markowitsch S., Schupp P., Lauckner J., et al. Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis. Cancers . 2020;12(11):p. 3150. doi: 10.3390/cancers12113150.", "ArticleIdList": ["10.3390/cancers12113150", "PMC7692972", "33121039"]}, {"Citation": "Zhang H., Ba S., Yang Z., et al. Graphene quantum dot-based nanocomposites for diagnosing cancer biomarker APE1 in living cells. ACS Applied Materials & Interfaces . 2020;12(12):13634\u201313643. doi: 10.1021/acsami.9b21385.", "ArticleIdList": ["10.1021/acsami.9b21385", "32129072"]}, {"Citation": "Visconti R., Grieco D. New insights on oxidative stress in cancer. Current Opinion in Drug Discovery & Development . 2009;12(2):240\u2013245.", "ArticleIdList": ["19333869"]}, {"Citation": "Ramdzan Z. M., Vickridge E., Faraco C. C. F., Nepveu A. CUT domain proteins in DNA repair and cancer. Cancers (Basel) . 2021;13(12):p. 2953. doi: 10.3390/cancers13122953.", "ArticleIdList": ["10.3390/cancers13122953", "PMC8231510", "34204734"]}, {"Citation": "Stockwell B. R., Friedmann Angeli J. P., Bayir H., et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell . 2017;171(2):273\u2013285. doi: 10.1016/j.cell.2017.09.021.", "ArticleIdList": ["10.1016/j.cell.2017.09.021", "PMC5685180", "28985560"]}, {"Citation": "Jiang X., Stockwell B. R., Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nature Reviews. Molecular Cell Biology . 2021;22(4):266\u2013282. doi: 10.1038/s41580-020-00324-8.", "ArticleIdList": ["10.1038/s41580-020-00324-8", "PMC8142022", "33495651"]}, {"Citation": "Viswanathan V. S., Ryan M. J., Dhruv H. D., et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature . 2017;547(7664):453\u2013457. doi: 10.1038/nature23007.", "ArticleIdList": ["10.1038/nature23007", "PMC5667900", "28678785"]}, {"Citation": "Lai H., Sasaki T., Singh N., Messay A. Effects of artemisinin-tagged holotransferrin on cancer cells. Life Sciences . 2005;76(11):1267\u20131279. doi: 10.1016/j.lfs.2004.08.020.", "ArticleIdList": ["10.1016/j.lfs.2004.08.020", "15642597"]}, {"Citation": "Drenberg C., Buaboonnam J., Orwick S., et al. Evaluation of artemisinins for the treatment of acute myeloid leukemia. Cancer Chemotherapy and Pharmacology . 2016;77(6):1231\u20131243. doi: 10.1007/s00280-016-3038-2.", "ArticleIdList": ["10.1007/s00280-016-3038-2", "PMC4918815", "27125973"]}, {"Citation": "Yu M., Gai C., Li Z., Ding D., Li W. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells. Cancer ence . 2019;110(10):3173\u20133182. doi: 10.1111/cas.14181.", "ArticleIdList": ["10.1111/cas.14181", "PMC6778638", "31464035"]}, {"Citation": "Chen J., Wang X., Zhang Y., et al. A redox-triggered C-centered free radicals nanogenerator for self-enhanced magnetic resonance imaging and chemodynamic therapy. Biomaterials . 2021;266, article 120457 doi: 10.1016/j.biomaterials.2020.120457.", "ArticleIdList": ["10.1016/j.biomaterials.2020.120457", "33096377"]}, {"Citation": "Fei W., Chen D., Tang H., et al. Targeted GSH-exhausting and hydroxyl radical self-producing manganese-silica nanomissiles for MRI guided ferroptotic cancer therapy. Nanoscale . 2020;12(32):16738\u201316754. doi: 10.1039/D0NR02396E.", "ArticleIdList": ["10.1039/D0NR02396E", "32578659"]}, {"Citation": "Vandewynckel Y. P., Laukens D., Geerts A., et al. Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent. European Journal of Gastroenterology & Hepatology . 2014;60(1):S85\u2013S85. doi: 10.1016/S0168-8278(14)60218-X.", "ArticleIdList": ["10.1016/S0168-8278(14)60218-X", "24987823"]}, {"Citation": "Jeong D., Song H., Lim S., et al. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis. Oncotarget . 2015;6(32):33046\u201333064. doi: 10.18632/oncotarget.5422.", "ArticleIdList": ["10.18632/oncotarget.5422", "PMC4741748", "26426994"]}, {"Citation": "Kast R., Boockvar J., Br\u00fcning A., et al. A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget . 2013;4(4):502\u2013530. doi: 10.18632/oncotarget.969.", "ArticleIdList": ["10.18632/oncotarget.969", "PMC3720600", "23594434"]}, {"Citation": "Augustin Y., Krishna S., Kumar D., Pantziarka P. The wisdom of crowds and the repurposing of artesunate as an anticancer drug. Ecancer medical science . 2015;9:p. ed50. doi: 10.3332/ecancer.2015.ed50.", "ArticleIdList": ["10.3332/ecancer.2015.ed50", "PMC4631583", "26557887"]}, {"Citation": "Galluzzi L., Senovilla L., Vitale I., et al. Molecular mechanisms of cisplatin resistance. Oncogene . 2012;31(15):1869\u20131883. doi: 10.1038/onc.2011.384.", "ArticleIdList": ["10.1038/onc.2011.384", "21892204"]}, {"Citation": "Reni M., Cereda S., Galli L. PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen. Cancer Letters . 2007;256(1):25\u201328. doi: 10.1016/j.canlet.2007.04.009.", "ArticleIdList": ["10.1016/j.canlet.2007.04.009", "17561341"]}, {"Citation": "Guo J., Xu B., Han Q., et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Research and Treatment . 2018;50(2):445\u2013460. doi: 10.4143/crt.2016.572.", "ArticleIdList": ["10.4143/crt.2016.572", "PMC5912137", "28494534"]}, {"Citation": "Zhu J., Xiong Y., Zhang Y., et al. The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors. Oxidative Medicine and Cellular Longevity . 2020;2020", "ArticleIdList": ["PMC7772020", "33425217"]}, {"Citation": "Nagpal A., Redvers R. P., Ling X., et al. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis. Breast Cancer Research . 2019;21(1):p. 94. doi: 10.1186/s13058-019-1177-1.", "ArticleIdList": ["10.1186/s13058-019-1177-1", "PMC6693253", "31409375"]}, {"Citation": "Qiu Y., Cao Y., Cao W., Jia Y., Lu N. The application of ferroptosis in diseases. Pharmacological Research . 2020;159, article 104919 doi: 10.1016/j.phrs.2020.104919.", "ArticleIdList": ["10.1016/j.phrs.2020.104919", "32464324"]}, {"Citation": "Escudier B., Worden F., Kudo M. Sorafenib: key lessons from over 10 years of experience. Expert Review of Anticancer Therapy . 2019;19(2):177\u2013189. doi: 10.1080/14737140.2019.1559058.", "ArticleIdList": ["10.1080/14737140.2019.1559058", "30575405"]}, {"Citation": "Plosker G. L., Croom K. F. Sulfasalazine. Drugs . 2005;65(13):1825\u20131849. doi: 10.2165/00003495-200565130-00008.", "ArticleIdList": ["10.2165/00003495-200565130-00008", "16114981"]}, {"Citation": "Yang L., Wang H., Yang X., et al. Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms. Signal Transduction and Targeted Therapy . 2020;5(1):p. 138. doi: 10.1038/s41392-020-00253-0.", "ArticleIdList": ["10.1038/s41392-020-00253-0", "PMC7393508", "32732975"]}, {"Citation": "Ericsson T., Blank A., von Hagens C., Ashton M., \u00c4bel\u00f6 A. Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer. European Journal of Clinical Pharmacology . 2014;70(12):1453\u20131463. doi: 10.1007/s00228-014-1754-2.", "ArticleIdList": ["10.1007/s00228-014-1754-2", "25248945"]}, {"Citation": "Krishna S., Ganapathi S., Ster I., et al. A randomised, double blind, placebo-controlled pilot study of oral artesunate therapy for colorectal cancer. Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer, EBioMedicine . 2015;2(1):82\u201390. doi: 10.1016/j.ebiom.2014.11.010.", "ArticleIdList": ["10.1016/j.ebiom.2014.11.010", "PMC4484515", "26137537"]}, {"Citation": "Deeken J., Wang H., Hartley M., et al. A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemotherapy and Pharmacology . 2018;81(3):587\u2013596. doi: 10.1007/s00280-018-3533-8.", "ArticleIdList": ["10.1007/s00280-018-3533-8", "29392450"]}, {"Citation": "von Hagens C., Walter-Sack I., Goeckenjan M., et al. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2) Phytomedicine : international journal of phytotherapy and phytopharmacology . 2019;54:140\u2013148. doi: 10.1016/j.phymed.2018.09.178.", "ArticleIdList": ["10.1016/j.phymed.2018.09.178", "30668363"]}, {"Citation": "K\u00f6nig M., von Hagens C., Hoth S., et al. Erratum to: investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study. Cancer Chemotherapy and Pharmacology . 2016;77(6):p. 1321. doi: 10.1007/s00280-016-3023-9.", "ArticleIdList": ["10.1007/s00280-016-3023-9", "27094900"]}, {"Citation": "Dabbagh A. J., Shwaery G. T., Keaney J. F. J., Frei B. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arteriosclerosis, Thrombosis, and Vascular Biology . 1997;17(11):2638\u20132645. doi: 10.1161/01.ATV.17.11.2638.", "ArticleIdList": ["10.1161/01.ATV.17.11.2638", "9409237"]}, {"Citation": "Huang J., Jones D., Luo B., et al. Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes . 2011;60(1):80\u201387. doi: 10.2337/db10-0593.", "ArticleIdList": ["10.2337/db10-0593", "PMC3012200", "20876715"]}, {"Citation": "Elena G., Stefania R., Ilona R., Paolo B., Gaetano C. Iron-induced damage in cardiomyopathy: oxidative-dependent and independent mechanisms. Oxidative Medicine and Cellular Longevity . 2015;2015230182", "ArticleIdList": ["PMC4387903", "25878762"]}, {"Citation": "Dominic H., Scott A., Ashley B., Peng L. A delicate balance: iron metabolism and diseases of the brain. Frontiers in Aging Neuroscience . 2013;5:p. 34.", "ArticleIdList": ["PMC3715022", "23874300"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "13"}, {"Year": "2021", "Month": "11", "Day": "2"}, {"Year": "2021", "Month": "11", "Day": "23"}, {"Year": "2022", "Month": "1", "Day": "14", "Hour": "6", "Minute": "2"}, {"Year": "2022", "Month": "1", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["35028002", "PMC8752222", "10.1155/2022/1458143"]}}], "PubmedBookArticle": []}